PROGRAM AGENDA

  • 8:10AM-8:50AM Controversies in Structural Heart Disease: Point/Counterpoint (Moderator: Paul Walinsky, MD) - Stroke Prevention in Atrial Fibrillation
    • Case Presentation - Nikhil Joshi, MD
    • Left Atrial Appendage Devices Obviate the Need for Anticoagulation - Daniel Frisch, MD
    • There is Limited Role for LAA Occlusive Devices in the Era of Newer Anticoagulants - Arnold Greenspon, MD
  • 8:50AM-9:30AM Controversies in Structural Heart Disease: Point/Counterpoint (Moderator: Paul Walinsky, MD) - Aortic Stenosis
    • ​TAVR will become the Treatment of choice for Moderate Risk Patients - Nicholas J. Ruggiero, MD
    • Surgery Remains the Treatment of Choice for Moderate Risk Patients - John Entwistle, III, MD, PhD
  • 9:30AM-9:45AM Break with Refreshments & Exhibitors
  • 9:45AM-10:45AM Acute Coronary Syndromes (Moderator: Matthew DeCaro, MD)
    • Case Presentation - Antony G. Kaliyadan, MD
    • Has the 90-Minute Door to Balloon Changed Clinical Outcomes?  - Howard H. Weitz, MD
    • What are the Roles of Thrombectomy, Laser Angioplasty and Mechanical Support Devices? - David L. Fischman, MD
    • Antiplatelet Therapy:  Which Drug and for How Long? - Gregary D. Marhefka, MD
    • Question & Answer
  • 10:45AM-11:45AM Ischemic Cardiomyopathy (Moderator: Howard H. Weitz, MD)
  • 11:45AM-12:45PM Lunch with Exhibitors
  • 12:45PM-1:45PM Renovascular Hypertension (Moderator: David L. Fischman, MD)
    • Incorporating Hypertension Guidelines into Clinical Practice - Seyed M. Hamrahian, MD
    • Is there a Role for Renal Artery Stenting? - Edward J. Filippone, MD
    • Renal Artery Denervation: Simplicity and Beyond - Nicholas J. Ruggiero, MD
    • Question & Answer